Cargando…
Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production
BACKGROUND: Human tuberculosis, which is caused by the pathogen Mycobacterium tuberculosis, remains a major public health concern. Increasing drug resistance poses a threat of disease resurgence and continues to cause considerable mortality worldwide, which necessitates the development of new drugs...
Autores principales: | Mahmud, Hafij Al, Seo, Hoonhee, Kim, Sukyung, Islam, Md Imtiazul, Nam, Kung-Woo, Cho, Hyun-Deuk, Song, Ho-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445392/ https://www.ncbi.nlm.nih.gov/pubmed/28545436 http://dx.doi.org/10.1186/s12906-017-1786-0 |
Ejemplares similares
-
A novel class of antimicrobial drugs selectively targets a Mycobacterium tuberculosis PE-PGRS protein
por: Seo, Hoonhee, et al.
Publicado: (2022) -
Melanin Bleaching and Melanogenesis Inhibition Effects of Pediococcus acidilactici PMC48 Isolated from Korean Perilla Leaf Kimchi
por: Kim, Sukyung, et al.
Publicado: (2020) -
Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis
por: Islam, Md Imtiazul, et al.
Publicado: (2021) -
Migration and Proliferation Effects of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) and Thymoquinone (TQ) on In Vitro Wound Healing Models
por: Alexander, Henna Roshini, et al.
Publicado: (2019) -
Increased Susceptibility of Mycobacterium tuberculosis to Ethionamide by Expressing PPs-Induced Rv0560c
por: Seo, Hoonhee, et al.
Publicado: (2022)